• Health & Medicine

Scottish Medicines Consortium says yes to chemotherapy-free leukaemia treatment

The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia. The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.

8 December 2020

• Health & Medicine

Prostate cancer treatment approved in England

Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer. Following its approval in Scotland 2 weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer.

30 November 2020

• Health & Medicine

COVID-19 referral drop fears for lung cancer patients in Wales

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

20 November 2020

• Health & Medicine

First ‘targeted’ bowel cancer treatment combo approved for NHS use in England 

The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.   The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.  

20 November 2020

• Health & Medicine

Chemotherapy free treatment for leukaemia given the green light for NHS in England

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England. A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

13 November 2020

• Health & Medicine

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

13 November 2020

• Health & Medicine
• Policy & Insight

Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic

We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve. We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.

9 November 2020

• Health & Medicine

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system. Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.

9 November 2020

• Health & Medicine

What's happened to cancer clinical trials during the COVID-19 pandemic?

As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic. As coronavirus cases continue to rise in the UK, we look at how cancer clinical trials have been affected by the pandemic.

4 November 2020

• Health & Medicine

News digest – lockdown, ovarian cancer blood test, statins and Government spending review

As many as 50,000 people in the UK have an undiagnosed cancer as a result of the disruption caused by coronavirus, according to Macmillan Cancer Support. As many as 50,000 people in the UK have an undiagnosed cancer as a result of the disruption caused by coronavirus, according to Macmillan Cancer Support.

31 October 2020

• Health & Medicine

Immunotherapy drug approved for head and neck cancer

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

26 October 2020

• Health & Medicine

GPs say elderly are not seeking help for potential cancer symptoms

53% of GPs say they are concerned that fewer older adults are contacting them with symptoms compared to before the pandemic, according to new findings 53% of GPs say they are concerned that fewer older adults are contacting them with symptoms compared to before the pandemic, according to new findings

23 October 2020